Pituitary adenoma and intracerebral aneurysms: case series, systematic review and meta-analysis
Clinical Snapshot
PICO Framework
| P — Population | Patients with pituitary adenomas |
| I — Intervention | Presence of pituitary adenoma |
| C — Comparator | General population without pituitary adenomas |
| O — Outcomes | Prevalence of intracranial aneurysms, clinical characteristics of coexistent conditions |
Bottom Line
This systematic review of 71 studies involving 5264 patients demonstrates that pituitary adenoma patients have a 4% prevalence of intracranial aneurysms, significantly higher than the general population. The association is stronger in females (8%) than males (6%). Most aneurysms occur in the cavernous segment of the internal carotid artery and are typically diagnosed after the pituitary adenoma. However, the very high heterogeneity between studies (I² = 92.1%) significantly limits confidence in these findings. While the data suggest increased vigilance for aneurysms in pituitary adenoma patients may be warranted, the substantial study heterogeneity prevents definitive clinical recommendations. Further high-quality prospective studies with standardized imaging protocols are needed before establishing formal screening guidelines.
Key Findings
P Value: p < 0.01 for comparison with general population
Effect Size: 4% pooled prevalence
Primary Outcome: Prevalence of intracranial aneurysms in pituitary adenoma patients
Nnt Or Sensitivity: Prevalence ratio approximately 2-3 times higher than general population
Confidence Interval: 95% CI: 2-4%
Clinical Application
Screening protocols may need consideration for high-risk pituitary adenoma patients Relevant to Australian endocrinology and neurosurgery practice; may inform TGA-approved imaging protocols and Medicare-funded screening strategies for selected patients Patients with pituitary adenomas, particularly macroadenomas and non-functioning adenomas
Abstract
PURPOSE: Intracranial aneurysms (IAs) and Pituitary Adenoma (PA) coexistence has been reported for decades, yet available evidence remains fragmented. We performed a systematic review and meta-analysis following PRISMA 2020 guidelines to assess clinical features of patients with both conditions and quantify the prevalence of IAs in PA patients. METHODS: PubMed and Embase were searched up to December 15, 2025. Studies reporting coexistence of IAs and PAs were included. Individual patient-level data (Group 1) and aggregate prevalence data (Group 2) were analyzed separately. Risk of bias (RoB) was assessed using Joanna Briggs Institute tools. All analyses were performed using metaprop function from the meta package in R software. RESULTS: Seventy-one studies met inclusion criteria. Most studies have a low RoB. In Group 1 (74 patients), PAs were predominantly macroadenomas (91.9%), most frequently non-functioning (40.5%). IAs were mainly in the cavernous segment of the internal carotid artery (33%). IA diagnosis occurred significantly later than PA diagnosis (p < 0.01). In Group 2 (5264 patients), the pooled prevalence of IAs among PAs was 4% (95% CI 2-4%; I² = 92.1%, τ² = 1.1050, p < 0.0001). Sex-stratified prevalence was 8% (95% CI: 6%-9%) in females and 6% (95% CI: 4%-7%) in males. IAs sex-specific prevalence was significantly higher in both male and female PA patients as compared to the general population (p < 0.01). CONCLUSION: Patients with PAs show a higher IAs prevalence compared with the general population, likely reflecting combined hemodynamic, anatomical, and endocrine influences.
References
- 1.Marino Picciola, V., Borghesi, M., Trombin, V., Chirico, S., Ambrosio, M. R., & Zatelli, M. C. (2026). Pituitary adenoma and intracerebral aneurysms: case series, systematic review and meta-analysis. Pituitary. https://doi.org/10.1210/jc.2008-0948
Related Research
European journal of radiology
A CT-based deep learning model to differentiate between benign and malignant adrenal lesions
3 Aug 2026
Journal of chemical information and modeling
A Unified Molecular Graph and Protein Language Model Framework for Predicting Human Drug-Hormone Receptor Interactions with Structure-Aware Validation
28 July 2026
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Differential effects of hormone therapy formulations on Parkinson's disease risk: a systematic review and meta-analysis
23 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service